Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04380610 · ClinicalTrials.gov registry record
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 120
- Enrollment target
NCT04380610 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 120 participants.
The verdict
NCT04380610 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The investigators will attempt to develop a more accurate equation to estimate eGFR in pediatric and adult sickle cell patients
Interventions
- DIAGNOSTIC_TEST iohexol GFR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-05-12 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04380610
The ClinicalTrials.gov registry entry for NCT04380610 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iohexol GFR is the first listed.
NCT04380610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04380610 about?
NCT04380610 is a clinical study titled "Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia". The investigators will attempt to develop a more accurate equation to estimate eGFR in pediatric and adult sickle cell patients
What is the current status of trial NCT04380610?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2021-05-12. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT04380610?
The interventions under investigation include: iohexol GFR (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04380610?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.